Optinose Reports First Quarter 2021 Financial Results and Operational Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
OptiNose (OPTN) Tops Q1 EPS by 4c, Revenues Beat
May 5, 2021 7:14 AM EDTOptiNose (NASDAQ: OPTN) reported Q1 EPS of ($0.49), $0.04 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $11.96 million versus the consensus estimate of $11.1 million.
XHANCE net revenues increased 55% in the first quarter of 2021 compared to first quarter 2020, stated CEO Peter Miller. We believe this is strong growth, particularly in the context of the continuing impact of the COVID-19 pandemic on the number of patients visiting physician offices and pandemic-related restrictions that continue to limit in-person detailing of physician offices by our territory managers. Improvement to the business environment is just... More
